Women with inherited mutations in the BRCA1 or BRCA2 genes have a greatly increased risk of developing early onset breast cancer and ovarian cancer and face difficult decisions about options for risk reduction and early detection [1–5]. This evidence concerns the gene BRCA2 and ovarian carcinoma.